Vimarsana
Biggest News Aggregation in the World

Page 3 - Stan Erck News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stan Erck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stan Erck Today - Breaking & Trending Today

2 Numbers That Should Make Novavax Shareholders Smile - Vimarsana News

2 Numbers That Should Make Novavax Shareholders Smile

Novavax executives are talking about making big bucks this year.

Source: fool.com
2 Numbers That Should Make Novavax Shareholders Smile - Vimarsana News

2 Numbers That Should Make Novavax Shareholders Smile

Novavax executives are talking about making big bucks this year.

Source: fool.com
Novavax Applies for FDA Authorization of Its Covid Vaccine - Vimarsana News

Novavax Applies for FDA Authorization of Its Covid Vaccine

The protein-based shot, already authorized in some parts of the world, has faced long delays, and it is not clear what role it will play in the United States.

Novavax Inc (NVAX) Q3 2021 Earnings Call Transcript - Vimarsana News

Novavax Inc (NVAX) Q3 2021 Earnings Call Transcript

NVAX earnings call for the period ending September 30, 2021.

Source: fool.com
Pfizer: New antiviral cuts Covid hospitalization, death risk up to 89 percent - Vimarsana News

Pfizer: New antiviral cuts Covid hospitalization, death risk up to 89 percent

Pfizer's new data on the drug, Paxlovid, came from an interim analysis of its Phase II/III trial among more than 770 high-risk adults with Covid-19 who were treated within three days of the onset of symptoms or given a placebo.